Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Neoplasms 2 Multiple Myeloma 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Tooth, Impacted 1 Stomach Neoplasms 1 Sepsis 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Postoperative Nausea and Vomiting 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Menstruation Disturbances 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma 1 Lymphedema 1 Lung Neoplasms 1 Insulin Resistance 1 Ileus 1 Hyperandrogenism 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

telavancin 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Alkaline Phosphatase 1 Acupuncture Therapy 1 2-Propanol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sepsis × Acupuncture Therapy × Clear all

NCT06344819 2026-05-22

An Acupuncture Study for People At High Risk for Sepsis

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡